Company intelligence / Profile preview

Altis CRO

Ownership: Private
Employees: ~130
Development stage: Commercial

Overview

Altis CRO is one of Turkey’s leading contract research organizations. Founded in 2001 by Dr. Emin Mehmet Yusuf, it provides comprehensive clinical trial management and regulatory affairs services to the pharmaceutical and biomedical industries. The company operates across all phases of clinical trials (Phase 1–4), observational studies, medical device studies, data management/statistics, patient support programs, site support services, and training. It is officially approved by the Turkish Medicines and Medical Devices Agency (TMMDA) and employs over 130 professionals across 17 cities in Turkey.

Therapeutic areas: PulmonologyOncologyEndocrinologyHematologyOtherPsychiatryGastroenterologyCardiovascularOphthalmologyInfectious Diseases
Modalities: Small moleculeBiologicMonoclonal antibodyMedical device studies
Industry: Contract Research Organization

Beyond the preview

Go deeper on Altis CRO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altis CRO.

Explore the full profile